Shares in Pacira Pharmaceuticals (NSDQ:PCRX) fell slightly today after the pharmaceutical company missed expectations on Wall Street with its second quarter results.
The Parsippany, N.J.-based company posted a net loss of -$19.7 million, or -49¢ per share, on sales of $70.9 million for the 3 months ended June 30, for bottom-line loss of -148% on sales growth of 2% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Pacira misses on Q2 sales, earnings appeared first on MassDevice.
from MassDevice http://ift.tt/2ukUATg
Cap comentari:
Publica un comentari a l'entrada